ADHARSH SAHADEVAN: Open Payments
NPI 1376703769 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 27 payments from 7 companies in 2025. Trend: 2023 $1,538 · 2024 $705 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $151 |
| Biogen, Inc. | 1 | $120 |
| ABBVIE INC. | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: ZURZUVAE, VRAYLAR, UZEDY, AUSTEDO XR, REXULTI, TRINTELLIX, CAPLYTA, FANAPT.
Industry payments across PA — which companies pay providers there.
